Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

125.85B

Market cap125.85B

Price-Earnings ratio

13.54

Price-Earnings ratio13.54

Dividend yield

4.08%

Dividend yield4.08%

Average volume

12.38M

Average volume12.38M

High today

—

High today—

Low today

—

Low today—

Open price

$61.49

Open price$61.49

Volume

0.00

Volume0.00

52 Week high

$68.64

52 Week high$68.64

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

With a market cap of 125.85B, Bristol-Myers Squibb(BMY) trades at $61.61. The stock has a price-to-earnings ratio of 13.54 and currently yields dividends of 4.08%.

On 2026-10-27, Bristol-Myers Squibb(BMY) stock opened at $61.49, reached a high of —, and a low of —.

Bristol-Myers Squibb(BMY) shares are trading with a volume of 0, against a daily average of 12.38M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $68.64 at its peak.

BMY News

The Motley Fool 6h

Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters - The Motley Fool

...

Zacks 18h

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?

Biotech giant Bristol-Myers Squibb Company (BMY Quick QuoteBMY - Free Report) is scheduled to report third-quarter 2026 results on Oct. 29, before market...

Zacks 24h

Bristol Myers Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

The upcoming report from Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) is expected to reveal quarterly earnings of $1.28 per share, indicating...

Analyst ratings

58%

of 31 ratings

Buy

35.5%

Hold

58.1%

Sell

6.5%

More BMY News

Simply Wall St 4d

Why Did Bristol-Myers Squibb Climb Today?

The latest clinical news around Bristol-Myers Squibb (BMY) centers on late stage oncology and pulmonary fibrosis programs, featuring new Phase 3 readouts and a...

TipRanks 4d

Tempus AI Expands Neurology Data Partnership With Pathos

The latest update is out from Tempus AI, Inc. Class A ( (TEM) ). On October 23, 2026, Tempus AI announced a series of agreements with Bristol-Myers Squibb and...

Simply Wall St 5d

Bristol Myers Squibb Stock May Be 49% Undervalued Despite Phase 3 Wins

has delivered a 43.8% gain over the past year, and with the stock recently closing at US$61.12, the question for you is whether that move lines up with the cash...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.